Search results
Leadless Pacing Wirelessly Linked to Subcutaneous Defibrillator Hits Targets for ATP
MedPage Today· 5 days agoA leadless pacemaker reliably communicated with a subcutaneous implantable...
Eli Lilly pays Aktis $60M upfront to further dial into radiopharma signal
FierceBiotech· 3 days agoEli Lilly is continuing to ride the radiopharma wave, paying Aktis Oncology $60 million upfront to...
Top pharma executives say lack of funding stalling digital revolution
BioPharma-Reporter· 3 days agoThe study, titled Disconnected Pharma, is based on 100 in-depth interviews with executives from...
Finding Undiagnosed Asthma, COPD and Treating It Shows Benefit in Trial
MedPage Today· 5 days agoIdentifying symptomatic individuals in the community with undiagnosed asthma and chronic obstructive...
Cytokinetics secures up to $575M in royalty deal, frustrating investors
BioPharma Dive via Yahoo Finance· 1 day agoThe biotech’s decision to give Royalty Pharma a greater share of future drug sales suggests a lower...
Exercise Improves Sexual Health in Metastatic Breast Cancer
Medscape· 3 days agoExercise can help improve sexual health in women with metastatic breast cancer and should be a key...
AstraZeneca’s $80B sales plan leans on cancer drug expansion
BioPharma Dive via Yahoo Finance· 3 days agoAstraZeneca also plans to make a mark in cell therapy, which has so far been led by Novartis, Gilead...
Exploring Swiss Dividend Stocks In May 2024
Simply Wall St. via Yahoo Finance· 2 days agoAs the Switzerland market experienced a downturn, extending losses with investors taking profits following a sustained period of gains, concerns about...
Is Vaginal Estrogen Safe in Breast Cancer Survivors?
Medscape· 2 days agoVaginal estrogen therapy appears to be safe after early breast cancer in patients with HR-negative tumors and those with HR-positive tumors concurrently...
Michael Cohen Admits Stealing From Trump in Fiery Day of Trial
The New York Sun· 3 days agoTuesday may be the last day of testimony in President Trump’s hush-money trial. If that wasn’t bad...